HBIO
Harvard Bioscience Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.47
-0.02 ▼ -4.15%
🌙 3월 13일 7:45 PM ET (한국 3/14 08:45)
$0.50
+0.02 ▲ +4.75%
| Index | - | P/E | - | EPS (ttm) | -1.28 | Insider Own | 5.81% | Shs Outstand | 0.04B | Perf Week | -13.91% |
| Market Cap | 0.02B | Forward P/E | 5.92 | EPS next Y | 180% | Insider Trans | - | Shs Float | 0.04B | Perf Month | -12.93% |
| Enterprise Value | 0.06B | PEG | - | EPS next Q | -0.03 | Inst Own | 46.64% | Short Float | 1.08% | Perf Quarter | -38.07% |
| Income | -0.06B | P/S | 0.24 | EPS this Y | -400% | Inst Trans | 5.19% | Short Ratio | 0.99 | Perf Half Y | 6.76% |
| Sales | 0.09B | P/B | 1.54 | EPS next 5Y | - | ROA | -54.86% | Short Interest | 0.45M | Perf YTD | -29.2% |
| Book/sh | 0.31 | P/C | 2.46 | EPS past 3/5Y | -77.14% -44.59% | ROE | -147.13% | 52W High | -49.94% ($0.95) | Perf Year | -26.03% |
| Cash/sh | 0.19 | P/FCF | 3.87 | Sales past 3/5Y | -8.6% -3.25% | ROIC | -100.38% | 52W Low | 68.33% ($0.28) | Perf 3Y | -81.5% |
| Dividend Est. | - | EV/EBITDA | 9.47 | EPS Y/Y TTM | -350.42% | Gross Margin | 53.01% | Volatility(W/M) | 12.88% 8.08% | Perf 5Y | -92.62% |
| Dividend TTM | - | EV/Sales | 0.66 | Sales Y/Y TTM | -8.06% | Oper. Margin | 0.12% | ATR (14) | 0.05 | Perf 10Y | -83.5% |
| Dividend Ex-Date | - | Quick Ratio | 1.25 | EPS Q/Q | -16050% | Profit Margin | -65.51% | RSI (14) | 36.22 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.2 | Sales Q/Q | -3.34% | SMA20 | -15.61% ($0.56) | Beta | 1.49 | Target Price | $0.6 |
| Payout | - | Debt/Eq | 3.23 | Earnings | 3000000 | SMA50 | -17.48% ($0.57) | Rel Volume | 1.07 | Prev Close | $0.49 |
| Employees | 339 | LT Debt/Eq | 3.11 | EPS/Sales Surpr. | -100% 2.75% | SMA200 | -11.96% ($0.53) | Avg Volume(3M) | 0.46M | Price | $0.47 |
| IPO | 2000/12/7 | Option/Short | Yes/Yes | Trades | 1004 | Volume | 488,351 | Change | -4.15% |
뉴스 로딩 중...